Extracorporeal Membrane Oxygenation Machine (ECMO) Market Size, Share, Competitive Landscape and Trend Analysis Report, by Type, by Components, by Application : Global Opportunity Analysis and Industry Forecast, 2024-2033

Key Market Dynamics 

The market for extracorporeal membrane oxygenation (ECMO) machines is significantly influenced by the rising incidence of severe cardiac and respiratory conditions, such as acute respiratory distress syndrome (ARDS) , chronic obstructive pulmonary disease (COPD) , and heart failure, which necessitates advanced life support systems like ECMO. Thus, such factors boost the ECMO machine market growth.

The safety and efficacy of ECMO machines are improved by ongoing technological advancements in oxygenators, biocompatible materials, and user-friendly interfaces and are also the ECMO machine market trends. ECMO machines are now more widely available for usage in a variety of therapeutic contexts, such as field hospitals and patient transport, because of advancements in portability and miniaturisation. As the population of elderly individuals increases, so does their vulnerability to severe cardiopulmonary disorders, which highlights the necessity for ECMO support in the management of these age-related health problems. 

Patent Analysis, 2015-2024 

Although the ECMO machine market share growth has been more rapid in recent years, the industry can draw on the patents filed by various companies across various countries. For instance, patents filed by China dominated the same with a 45.5% share, the U.S. holds a share of about 9.1% and the Patent Cooperation Treaty (PCT) holds a share of about 20.5%. 

Market Segmentation 

The ECMO machine market analysis is segmented on the basis of type, component, application, and region. Based on type, the market is classified into veno-arterial, veno-venous, and arterio-venous. As per component, the market is classified into pumps, oxygenator, controllers, and others. Based on application, the market is classified into adult, pediatric, and neonates. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

Regional/Country Market Outlook 

North America accounted for a major ECMO machine market size market owing to the presence of several major players, availability of advanced healthcare facilities; and high healthcare infrastructure expenditure by the government organizations in the region which drive the growth of the market.?Moreover, this is attributed to the rise in incidences of chronic diseases, and the strong presence of key market players in the region. 

Asia-Pacific ECMO machine market share is estimated to grow with the highest CAGR during the forecast period, owing to enhancements in healthcare facilities, increase in prevalence of chronic diseases, surge in awareness about early disease diagnosis, and increase in healthcare expenditure. In addition, this region offers lucrative opportunities for the extracorporeal membrane oxygenation (ECMO) machine market key players, owing to a rising awareness of advanced medical technologies. Companies are focusing on this region to expand their market presence. 

Industry Trends

• Innovations leading to smaller, portable ECMO systems that can be used outside traditional ICU settings, including during patient transport and in emergency situations. 
• Incorporation of digital health technologies, such as remote monitoring, data analytics, and artificial intelligence, to improve patient management and outcomes. 

Competitive Landscape 

The major players operating in the extracorporeal membrane oxygenation (ECMO) machine market are Medtronic Plc, Sorin Group, Terumo Corporation, MAQUET Holding, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, Getinge AB, Livanova Plc, and Fresnius Medical Care. 

Recent Developments 

• In November 2022, LivaNova PLC a market-leading medical technology and innovation company, announced it received 510 (k) clearance for extracorporeal membrane oxygenation (ECMO) from the U.S. Food and Drug Administration (FDA) for LifeSPARC, the Company’s next-generation Advanced Circulatory Support (ACS) pump and controller system. 
• In July 11, 2022, Inspira Technologies OXY B.H.N. Ltd. announced the "Liby" System, an advanced form of life support the extracorporeal membrane oxygenation (ECMO) machine, used to treat patients with life-threatening heart and lung failure. 

Key Sources Referred 

• National Center for Biotechnology Information 
• World Health Organization (WHO)  
• National Library of Medicine 
• The United States Food and Drug Administration 
• U.S. Department of Health & Human Services 
• Centers for Disease Control and Prevention 
• Australian Institute of Health and Welfare 
• Johns Hopkins Medicine 
• National Centre for Disease Control (NCDC)  
• American Heart Association, Inc. 
• NHS Blood and Transplant 

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the  extracorporeal membrane oxygenation machine market from 2024 to 2033 to identify the prevailing extracorporeal membrane oxygenation machine market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the ECMO machine industry players segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the ECMO machine industry players.
• The report includes the analysis of the regional as well as global ECMO machine market forecast, key players, market segments, application areas, and market growth strategies.